NYSE:DGX Quest Diagnostics Q3 2026 Earnings Report $235.25 -1.07 (-0.45%) As of 11:32 AM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast Quest Diagnostics EPS ResultsActual EPSN/AConsensus EPS $2.87Beat/MissN/AOne Year Ago EPSN/AQuest Diagnostics Revenue ResultsActual RevenueN/AExpected Revenue$3.04 billionBeat/MissN/AYoY Revenue GrowthN/AQuest Diagnostics Announcement DetailsQuarterQ3 2026Date10/22/2026TimeBefore Market OpensConference Call DateThursday, October 22, 2026Conference Call Time8:30AM ETConference Call ResourcesEarnings HistoryCompany Profile Quest Diagnostics Earnings HeadlinesQuest Diagnostics (DGX) Could Be 5% Below Fair Value After Apple Health LaunchSeptember 23, 2026 | finance.yahoo.comQuest Diagnostics Incorporated: Testing Growth Keeps Me Bullish Despite Medicare HeadwindsSeptember 23, 2026 | seekingalpha.comMeet the drone firm selected for the Pentagon's counter-drone programOne Nasdaq-listed drone company already supplies the US Army, Air Force, and Navy with mission-ready drone systems for reconnaissance and tactical operations. Now, alongside F4 Defense International, it has been selected by the Department of War to build a next-generation counter-drone system that detects, tracks, and defeats hostile drones. The company is also integrating Palladyne AI's SwarmOS platform for autonomous swarm intelligence, with commercial clients including Shell, Ford, and Red Bull.September 28 at 1:00 AM | Tomorrow Investor (Ad)Comparing GeneDx (NASDAQ:WGS) and Quest Diagnostics (NYSE:DGX)September 23, 2026 | americanbankingnews.comQuest Diagnostics (DGX) Stock Could Be 30% Below Fair Value Following Medicare Payment Cut ConcernsSeptember 22, 2026 | finance.yahoo.comQuest Diagnostics to Release Third Quarter Financial Results on October 22, 2026September 22, 2026 | prnewswire.comSee More Quest Diagnostics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Quest Diagnostics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Quest Diagnostics and other key companies, straight to your email. Email Address About Quest DiagnosticsQuest Diagnostics (NYSE:DGX) (NYSE: DGX) is a provider of diagnostic information services. The company performs laboratory testing used to help diagnose, monitor and manage diseases and other health conditions, serving physicians, hospitals, health plans, employers, government agencies and individual consumers. Its services include routine blood and urine testing, advanced and esoteric diagnostics, molecular and genetic testing, anatomic pathology, cancer testing, drug screening and wellness-related assessments. Quest also provides laboratory management and diagnostic support services for hospitals and other healthcare organizations, as well as consumer-ordered testing through its retail and digital channels. Quest Diagnostics traces its roots to laboratories established by Corning Incorporated and became an independent public company in 1996. The company is headquartered in Secaucus, New Jersey, and primarily serves customers throughout the United States through a network of laboratories, patient service centers and other healthcare partnerships. Quest is led by President and Chief Executive Officer Jim Davis.View Quest Diagnostics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 09/21 - 09/252 Cybersecurity Stocks Breaking Out as AI Continues to Be a TailwindFertilizer Prices Keep Climbing: 3 Stocks Still Trading at a DiscountCostco Ends Its Fiscal Year on a High Note, Eyes Big ExpansionCracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem5 Scary-Good Stocks With Strong October Catalysts and Breakout PotentialDarden Restaurants Serves Up Fresh Catalysts for a Stock Price Rally Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
